Related Experiment Video
Updated: May 5, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Asymptomatic Lambert-Eaton syndrome
1Department of Neurosciences, California Pacific Medical Center, San Francisco, California, USA.
This study identified asymptomatic Lambert-Eaton syndrome (LES) in a patient, showing presynaptic disorder markers and P/Q-type voltage-gated calcium channel antibodies. This finding offers new insights into the natural history of LES.
Area of Science:
- Neurology
- Clinical Electrophysiology
- Autoimmunity
Background:
- Lambert-Eaton syndrome (LES) is typically described in symptomatic individuals.
- This case presents incidental electromyographic findings suggestive of LES in an asymptomatic patient.
- The patient had controlled hypothyroidism and a history of smoking but no weakness or cancer.
Observation:
- Electrophysiological and serological evaluations were performed.
- Neuromuscular transmission tests indicated a presynaptic disorder.
- The patient had autoantibodies specific for P/Q-type voltage-gated calcium channels (VGCC) in serum.
Findings:
- Asymptomatic LES was identified and persisted for 8 years.
- P/Q-type VGCC autoantibodies were detected and remained throughout the follow-up period.
- Markers of thyrogastric autoimmunity were also present.
Implications:
- This case provides novel insight into the natural history of subclinical LES.
- Patients with subclinical LES may experience abrupt neuromuscular decompensation when exposed to certain medications.
- Understanding subclinical LES is crucial for managing neuromuscular disorders and patient safety.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Myasthenia Gravis ll: Pathophysiology
Arboviral Encephalitis
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

